Chapter Ten - Immunomodulatory effect of vitamin D on immune response to dengue virus infection
Vitamins and Hormones. Volume 117, 2021, Pages 239-252, https://doi.org/10.1016/bs.vh.2021.06.001
K.Alagarasu publisher rents the PDF for $31.50
Vitamin D can inhibit enveloped virus (e.g. Corona, Herpes, Bird Flu, Epstein, Hepatitis, RSV, etc.) – March 2011
SARS, SARS-COV2, and Dengue are enveloped
VitaminDWiki pages containing DENGUE in title
This list is automatically updated
COVID-19 treated by Vitamin D - studies, reports, videos
- As of March 31, 2024, the VitaminDWiki COVID page had: trial results, meta-analyses and reviews, Mortality studies see related: Governments, HealthProblems, Hospitals, Dark Skins, All 26 COVID risk factors are associated with low Vit D, Fight COVID-19 with 50K Vit D weekly Vaccines Take lots of Vitamin D at first signs of COVID 166 COVID Clinical Trials using Vitamin D (Aug 2023) Prevent a COVID death: 9 dollars of Vitamin D or 900,000 dollars of vaccine - Aug 2023
5 most-recently changed Virus entries
Dengue, an acute febrile illness which in some cases requires hospitalization and occasionally a fatal disease, caused by dengue virus is a potential threat to the public health systems throughout the world. Approved antivirals are not available for treating dengue. Immunomodulators, that can reduce inflammation which if not treated properly results in vascular leakage, are being attempted as therapeutics against severe dengue. Vitamin D, an immunomodulatory hormone, with both antiviral and immunomodulatory effects, is an appropriate choice for investigation as a potential drug against dengue.
Investigations of vitamin D levels by many studies have suggested vitamin D levels as a potential marker for predicting severe dengue. In-vitro studies have shown that 1, 25 dihydroxy vitamin D3 (1,25(OH)2D3), active form of vitamin D, can reduce the expression of dengue virus entry receptors, restrict the viral replication and can modulate the expression of inflammatory cytokines in dengue virus infected cells.
The results from in-vitro studies also have cautioned that insufficient levels of vitamin D supplementation might increase the virus replication. Available evidence suggests vitamin D based therapeutics against dengue and provides ray of light for treating dengue patients but, the available evidence needs to be supported by beneficial outcomes in clinical trials.
Table of Contents
1. Introduction
2. Synthesis of vitamin D and its mode of action
3. Circulating levels of vitamin D in DENV infected subjects
4. Immunomodulatory effects of vitamin D on the immune response to DENV
5. Vitamin D, a double-edged sword in dengue disease (low D ==> increases DENV)
6. Vitamin D receptor agonists: A novel therapeutic strategy against DENV
7. Vitamin D receptor gene variants and dengue
8. Clinical trials investigating the effects of vitamin D supplementation in reducing severe dengue
9. Conclusions